Literature DB >> 18642033

Data mining using template-based molecular docking on tetrahydroimidazo-[4,5,1-jk][1,4]-benzodiazepinone (TIBO) derivatives as HIV-1RT inhibitors.

Nitin S Sapre1, Swagata Gupta, Nilanjana Pancholi, Neelima Sapre.   

Abstract

TIBO (Tetrahydroimidazo-[4,5,1-jk][1,4]-benzodiazepinone) compounds are potent non-nucleoside reverse transcriptase inhibitors (NNRTIs) that show a great promise for the treatment of AIDS. A structure-based molecular modeling approach based on template-based flexible docking simulation followed by 'Tabu clustering' was performed on a series of 46 TIBO derivatives considered as training set of HIV-1 NNRTIs. Four different templates of the highest active ligand (pIC(50) = 8.52) of the series were used. The results were reasonably satisfactory. A good correlation was observed between the biological activity and binding affinity of the compounds, which suggest that identified binding conformations of these inhibitors are reliable. Statistical modeling yielded satisfactory results (r(2) = 0.878). Our studies suggest that template-based docking followed by 'Tabu clustering' enhances the docking efficiency. Also, cross-validation with a test-set containing 16 compounds gave satisfactory results (r(2) = 0.836). Data mining of PubChem database yielded a total of 31 hits (25 novel TIBO like compounds, as well as, 6 novel scaffolds) with enhanced binding efficacy as hits. These hits may, be targeted toward potent lead-optimization and, help in designing and synthesizing novel compounds with enhanced therapeutic efficacy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18642033     DOI: 10.1007/s00894-008-0335-7

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  40 in total

Review 1.  The picture of future therapy.

Authors:  B Gazzard
Journal:  Int J Clin Pract Suppl       Date:  1999-06

Review 2.  Non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors: past, present, and future perspectives.

Authors:  Giuseppe Campiani; Anna Ramunno; Giovanni Maga; Vito Nacci; Caterina Fattorusso; Bruno Catalanotti; Elena Morelli; Ettore Novellino
Journal:  Curr Pharm Des       Date:  2002       Impact factor: 3.116

3.  A discussion of measures of enrichment in virtual screening: comparing the information content of descriptors with increasing levels of sophistication.

Authors:  Andreas Bender; Robert C Glen
Journal:  J Chem Inf Model       Date:  2005 Sep-Oct       Impact factor: 4.956

4.  Molecular docking studies on 4-thiazolidinones as HIV-1 RT inhibitors.

Authors:  Ravindra K Rawal; Ashutosh Kumar; Mohammad Imran Siddiqi; Setu B Katti
Journal:  J Mol Model       Date:  2006-09-13       Impact factor: 1.810

5.  High resolution structures of HIV-1 RT from four RT-inhibitor complexes.

Authors:  J Ren; R Esnouf; E Garman; D Somers; C Ross; I Kirby; J Keeling; G Darby; Y Jones; D Stuart
Journal:  Nat Struct Biol       Date:  1995-04

6.  Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitors.

Authors:  A L Hopkins; J Ren; R M Esnouf; B E Willcox; E Y Jones; C Ross; T Miyasaka; R T Walker; H Tanaka; D K Stammers; D I Stuart
Journal:  J Med Chem       Date:  1996-04-12       Impact factor: 7.446

7.  The art of 'HAART': researchers probe the potential and limits of aggressive HIV treatments.

Authors:  J Stephenson
Journal:  JAMA       Date:  1997-02-26       Impact factor: 56.272

8.  Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives.

Authors:  R Pauwels; K Andries; J Desmyter; D Schols; M J Kukla; H J Breslin; A Raeymaeckers; J Van Gelder; R Woestenborghs; J Heykants
Journal:  Nature       Date:  1990-02-01       Impact factor: 49.962

Review 9.  Current status of the non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1.

Authors:  J Balzarini
Journal:  Curr Top Med Chem       Date:  2004       Impact factor: 3.295

Review 10.  Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance.

Authors:  C Tantillo; J Ding; A Jacobo-Molina; R G Nanni; P L Boyer; S H Hughes; R Pauwels; K Andries; P A Janssen; E Arnold
Journal:  J Mol Biol       Date:  1994-10-28       Impact factor: 5.469

View more
  1 in total

Review 1.  Therapeutic strategies underpinning the development of novel techniques for the treatment of HIV infection.

Authors:  Jian J Tan; Xiao J Cong; Li M Hu; Cun X Wang; Lee Jia; Xing-Jie Liang
Journal:  Drug Discov Today       Date:  2010-01-22       Impact factor: 7.851

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.